drugset / Trial / NCT01166646

Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

NCT01166646 ↗

Phase 2 Completed 43 enrolled Therapeutics, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether the investigational lotion is an effective treatment of moderate to severe plaque psoriasis in comparison to an approved cream.

Timeline

Start
2010-07
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Halobetasol Proprionate Unknown 3.5 g Topical

Indications